BRD2 and peripheral arterial disease: We also show that heterozygous carriers of an NAT haplotype in the 2q35 region carry a 22.6% risk of PAD compared to 12.9% for non-carriers (OR = 1.98, 95% CI 1.34–2.88, p < 0.00045) (Figure 4B).